JM

John F. McElroy

JD Jenrin Discovery: 27 patents #1 of 5Top 20%
DP Dupont Pharmaceuticals: 1 patents #101 of 197Top 55%
WF Wisys Technology Foundation: 1 patents #32 of 153Top 25%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
Overall (All Time): #107,755 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDate
11179370 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Robert J. Chorvat 2021-11-23
10617673 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2020-04-14
9987253 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2018-06-05
9517228 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2016-12-13
9133127 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Robert J. Chorvat 2015-09-15
8853252 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2014-10-07
8716265 4-quinolinemethanols as anti-malarial agents Robert J. Chorvat, David Nugiel 2014-05-06
8680131 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Robert J. Chorvat 2014-03-25
8648072 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2014-02-11
8580768 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2013-11-12
8541475 MAO-B inhibitors useful for treating obesity Robert J. Chorvat, Parthasarathi Rajagopalan 2013-09-24
8334282 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2012-12-18
8252791 Purine compounds as cannabinoid receptor blockers Robert J. Chorvat 2012-08-28
8236821 Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Robert J. Chorvat 2012-08-07
8217038 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2012-07-10
8138209 Substituted picolinamides as MAO-B inhibitors useful for treating obesity Robert J. Chorvat, Rajagopalan Parthasarathi 2012-03-20
8138216 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2012-03-20
8133904 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Robert J. Chorvat 2012-03-13
8124802 MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity Robert J. Chorvat 2012-02-28
8088926 Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity Robert J. Chorvat 2012-01-03
8088809 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2012-01-03
8088798 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Robert J. Chorvat 2012-01-03
7956220 MAO-B inhibitors useful for treating obesity Robert J. Chorvat, Rajagopalan Parthasarathi 2011-06-07
7759335 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Robert J. Chorvat 2010-07-20
7687481 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity Robert J. Chorvat 2010-03-30